The Potential of AI in the Healthcare Supply Chain

Grand View Research estimates the global AI market will grow at a compound annual rate of 57% between 2017 and 2025, reaching $36 billion. Forrester predicts that 2020 is the year executives will focus on how to drive and measure the value of their investments in AI. A recent survey of healthcare executives conducted by Optum found that not only is use of AI on the rise, but also that most executives expect a faster return on their investments than first anticipated. What's missing from these lofty projections are more substantive discussions about what's required to ensure that AI can deliver on its promise, such as the importance of data governance and management. There are also fewer conversations about the role AI and machine learning can play in the healthcare supply chain, compared with other areas, such as improved disease diagnosis and drug development. But when you stop and think about how AI is being applied elsewhere in healthcare, you begin to see implications and opportunities for the supply chain.